Home/Filings/4/0001593968-25-000305
4//SEC Filing

Draghia-Akli Ruxandra 4

Accession 0001593968-25-000305

CIK 0001000694other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:04 PM ET

Size

7.9 KB

Accession

0001593968-25-000305

Insider Transaction Report

Form 4
Period: 2025-03-03
Transactions
  • Award

    2025 Non-statutory Stock Option NQ

    2025-03-03$7.87/sh+120,000$944,400120,000 total
    Exercise: $7.87Exp: 2035-03-03Common Stock (120,000 underlying)
  • Award

    2025 Restricted Stock Units RSU

    2025-03-03+80,00080,000 total
    Exercise: $0.00Exp: 2035-03-03Common Stock (80,000 underlying)
Footnotes (2)
  • [F1]Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.
  • [F2]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.

Issuer

NOVAVAX INC

CIK 0001000694

Entity typeother

Related Parties

1
  • filerCIK 0002041719

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:04 PM ET
Size
7.9 KB